Skip To Content
bool(false)

New Gene Therapy Clinical Trials for Achromatopsia

At Fighting Blindness Canada, we are committed to accelerating the development of new sight-saving treatments for a variety of blinding eye diseases. Clinical trials are an essential step in developing those treatments,…

The Era of Gene Therapy – A Panel Discussion

In this panel discussion from Vision Quest Vancouver on April 27, 2019, experts from around the world introduced the new era of gene therapy and discussed what this means for the future…

New Gene Therapy Clinical Trial in Canada for Blinding Eye Disease

One of our core goals at Fighting Blindness Canada is to accelerate the development of new sight-saving treatments. Lately, we have been writing a lot about the exciting progress in gene therapy,…

GENE THERAPY & Clinical Trials TO TREAT VISION LOSS

When it comes to innovative therapies for treating eye diseases no approach has gained more attention than gene therapy. And rightfully so. The first gene therapy for any eye disease (Luxturna®) was…

“Gene Therapy Has Arrived!”

Canada’s first ocular gene therapy clinical trial was led by Dr. Ian MacDonald. The FBC was proud to be one of the funders who made this trial possible – as Dr. MacDonald…

The Difference Between Gene Therapy and Stem Cell Therapy [Facebook Live] (Video)

Watch our Facebook Live session from Friday, March 23, where we were joined online by special guest Dr. Jill Dolgin from the gene therapy company AGTC. In this video, Dr. Mary Sunderland…

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.

I have read and accepted the privacy policy